Skip to main content
Medtronic8-K: Spinoff

Medtronic subsidiary MiniMed completes 10% IPO, causing $0.04 EPS dilution in Q4 FY26.

What happened

The recent IPO of 10% of the MiniMed subsidiary creates a new public company and introduces financial complexity for Medtronic, including a $0.04 per share dilutive impact in Q4. This structural change could lead to reviews of inter-company systems, financial reporting tools, and operational processes between Medtronic and the newly public MiniMed.

Source

SEC EDGARMar 24, 2026

Current report (Form 8-K)

Medtronic 8-K

Filing excerpt

In addition, as previously disclosed during the Company’s Q3 earnings call, the timing of the March 9, 2026 closing of the initial public offering (IPO) of 10% of MiniMed is expected to result in dilution of approximately $0.02 per share to Medtronic shareholders for each month of the quarter following the IPO.

sec.gov/Archives/edgar/data/1613103/000161310326000005/mdt-20260324.htmRead the full source

Other signals in this filing (5)

Extracted by Autobound

From the Signal API record
Signal
8-K: Spinoff

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Fiscal year end
03/24
Filed
Mar 24, 2026

The full record

From the Signal API record

Numbers

Percent
10% (Portion of MiniMed subsidiary sold in an initial public offering (IPO).)

Details

CIK
1613103
Accession number
0001613103-26-000005
Timeframe
Current quarter
Filing year
2026
Why it matters
New entity needs vendors
Signal category
Strategic

Extraction

Confidence
High
Relevance
80%
Sentiment
Neutral
Detected
Mar 31, 2026
signal_type
sec-8k
signal_subtype
spinoff

Use this data

Get every 8-K signal for Medtronic and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Medtronic this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/3216b578-e58e-4b09-9af6-570d59840a86 returns this record as JSON. POST /v1/companies/enrich returns every signal for medtronic.com.

{
  "signal_id": "3216b578-e58e-4b09-9af6-570d59840a86",
  "signal_type": "sec-8k",
  "signal_subtype": "spinoff",
  "detected_at": "2026-03-31T08:16:22.923+00:00",
  "company": {
    "name": "Medtronic",
    "domain": "medtronic.com"
  },
  "data": {
    "detail": "The recent IPO of 10% of the MiniMed subsidiary creates a new public company and introduces financial complexity for Medtronic, including a $0.04 per share dilutive impact in Q4. This structural change could lead to reviews of inter-company systems, financial reporting tools, and operational processes between Medtronic and the newly public MiniMed.",
    "metrics": {
      "pct": 0.1,
      "timeframe": "current_quarter",
      "pct_context": "Portion of MiniMed subsidiary sold in an initial public offering (IPO).",
      "dollar_context": "Aggregate dilutive impact of $0.04 per share."
    },
    "summary": "Medtronic subsidiary MiniMed completes 10% IPO, causing $0.04 EPS dilution in Q4 FY26.",
    "excerpts": "In addition, as previously disclosed during the Company’s Q3 earnings call, the timing of the March 9, 2026 closing of the initial public offering (IPO) of 10% of MiniMed is expected to result in dilution of approximately $0.02 per share to Medtronic shareholders for each month of the quarter following the IPO.",
    "relevance": 0.8,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1613103/000161310326000005/mdt-20260324.htm",
    "filing_date": "2026-03-24",
    "filing_year": 2026,
    "fiscal_year_end": "03/24",
    "sales_relevance": "New entity needs vendors",
    "signal_category": "strategic"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.